CSF Monoamine Metabolites and Somatostatin in Alzheimer's Disease and Major Depression

Biological Psychiatry - Netherlands
doi 10.1016/0006-3223(91)90253-i
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The TRH Stimulation Test in Alzheimer's Disease and Major Depression: Relationship to Clinical and CSF Measures

Biological Psychiatry
Biological Psychiatry
1991English

Somatostatin and Alzheimer's Disease

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2008English

Early Death and CSF Monoamine Metabolites in Schizophrenia Spectrum Psychosis

Nordic Journal of Psychiatry
PsychiatryMental Health
2010English

Striatal Monoamine Terminals in Lewy Body Dementia and Alzheimer's Disease

Annals of Neurology
Neurology
2004English

Altered Monoamine and Acylcarnitine Metabolites in HIV-Positive and HIV-Negative Subjects With Depression

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2015English

CSF Biomarkers and the Diagnosis of Variant Forms of Alzheimer's Disease

Progress in Neurology and Psychiatry
PsychiatryMental HealthNeurologyPsychiatric Mental Health
2017English

Frontal Variant of Alzheimer's Disease: Clinico-CSF-Pathological Correlation

Canadian Journal of Neurological Sciences
MedicineNeurology
2010English

Comparison of Communication Abilities in Late Onset Depression and Alzheimer's Disease

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2009English

Circulating Antibodies to IDO/THO Pathway Metabolites in Alzheimer's Disease

International Journal of Alzheimer's Disease
AgingCognitive NeuroscienceMolecular NeuroscienceNeurologyBehavioral NeuroscienceCellular
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy